GlassScriptPhysician profile
Jessica Ramirez
NPI 1730590654
$9,578.75
in general payments reported to CMS, 2019-2025
30 companies · $2,454 in 2025
The $2,454 reported for 2025 was more than what 93% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,060 · 2022: $286 · 2023: $2,055 · 2024: $3,724 · 2025: $2,454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,174 · Travel and Lodging: $1,954 · Consulting Fee: $940 · Education: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,173.64 |
| Travel and Lodging | $1,954.16 |
| Consulting Fee | $940.00 |
| Education | $164.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $3,110.86 | 2021-2024 | Axonics, Bulkamid |
| Medtronic, INC. | $1,304.92 | 2021-2024 | Interstim |
| Janssen Scientific Affairs, LLC | $1,290.55 | 2023-2025 | Erleada |
| Teleflex LLC | $440.10 | 2024-2025 | Urolift, Barrigel |
| Boston Scientific Corporation | $389.24 | 2023-2025 | Axonics, Spaceoar Vue System - 10ml |
| Astellas Pharma US INC | $329.20 | 2021-2025 | Xtandi |
| Coloplast Corp | $315.61 | 2023-2025 | Altis, Speedicath |
| Procept Biorobotics Corporation | $302.60 | 2023-2024 | Aquabeam Robotic System, Aquabeam System |
| Dendreon Pharmaceuticals LLC | $260.11 | 2021-2025 | Provenge |
| Myovant Sciences INC. | $243.84 | 2021 | |
| Pfizer INC. | $221.13 | 2021-2024 | |
| Sumitomo Pharma America, INC. | $181.50 | 2023-2025 | Orgovyx, Gemtesa |
| Abbvie INC. | $174.08 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $131.32 | 2023-2024 | Lynparza |
| Olympus America INC. | $120.74 | 2025 | Itind System |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $110.32 | 2022-2023 | Xgeva |
| Ferring Pharmaceuticals INC. | $103.35 | 2025 | Adstiladrin |
| Merck Sharp & Dohme LLC | $97.06 | 2022-2025 | Welireg, Keytruda, Keytruda Qlex |
| Janssen Biotech, INC. | $68.00 | 2025 | Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $63.26 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $50.65 | 2025 | |
| Urogen Pharma, INC. | $45.71 | 2022-2025 | |
| 180 Medical, INC. | $45.46 | 2022-2024 | |
| Laborie Medical Technologies Corp. | $36.86 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Integra Lifesciences Corporation | $31.66 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Abc Home Medical Supply, INC. | $25.15 | 2025 | |
| Cardinal Health 414 LLC | $24.99 | 2025 | Kit For The Preparation of Lymphoseek (Technetium Tc 99m Tilmanocept) |
| Tolmar, INC. | $24.37 | 2023 | |
| Convatec INC. | $20.38 | 2025 | |
| Travere Therapeutics, INC. | $15.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.